Home  

Enter a class name or drug name above to search the database.

Decreased Immunologically Active Molecule Activity [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
59572-205 Thalomid Thalidomide Celgene Corporation CAPSULE 2003-06-20
59572-210 Thalomid Thalidomide Celgene Corporation CAPSULE 2003-06-20
59572-215 Thalomid Thalidomide Celgene Corporation CAPSULE 2007-03-20
59572-220 Thalomid Thalidomide Celgene Corporation CAPSULE 2003-06-20

 Physiological Effect (PE) Classification 

Loading full table content...